US EditionHow Much Progress Has Been Made Against Alzheimer's Disease?
Eli Lilly and Biogen's drugs slow Alzheimer's progression but face cost and approval challenges; about 70% of dementia cases are Alzheimer's, a leading elderly death cause.
- Two new Alzheimer’s treatments, donanemab and lecanemab , and a new blood test have recently emerged amid ongoing research and debate.
- This development follows decades of limited progress, with disputes over diagnosis methods and mixed reception from national health regulators worldwide.
- The blood test, authorized in the US since May but not yet in Europe, offers a less invasive alternative to lumbar punctures for detecting biological markers.
- Though the treatments slow disease progression modestly and mainly help early-stage patients, they carry serious risks such as brain haemorrhages, and reimbursement is limited.
- Experts highlight nearly half of Alzheimer’s cases link to lifestyle factors, and long-term trials remain necessary to prove effectiveness or prevention potential conclusively.
57 Articles
57 Articles
Newsbug.info
How much progress has been made against Alzheimer's disease?
After decades of unsuccessful research, two new drugs and a pioneering blood test have recently given Alzheimer's patients hope of fighting back against the debilitating disease -- but questions remain about their effectiveness.
How much progress has been made against Alzheimer’s disease?
After decades of unsuccessful research, two new drugs and a pioneering blood test have recently given Alzheimer's patients hope of fighting back against the debilitating disease -- but questions remain about their effectiveness. Any path toward a cure also remains elusive for Alzheimer's, which accounts for around 70 percent of dementia cases worldwide and is
How Much Progress Has Been Made Against Alzheimer's Disease? - Pakistan Live News
An Alzheimer’s patient rests on a bench after a walk at the Village Landais Alzheimer site in Dax, France, September 24, 2020. — Reuters PARIS: After decades of unsuccessful research, two new drugs and a pioneering blood test have recently given Alzheimer’s patients hope of fighting back against the debilitating disease — but questions remain about their effectiveness. Any path toward a cure also remains elusive for Alzheimer’s, which accounts …
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
